Company: NIVFW
Filing Date: 2025-05-01
Form Type: F-1/A
Source: 0001213900-25-038045
Chunk: 171

Company: NewGenIvf Group Ltd
Filing Date: 2025-05-01
Form: F-1/A
Chunk 171
---
 November 11, 2024, the Company closed on the third tranche of the 2024 Debt Financing pursuant to the terms of the Securities Purchase Agreement. Under the third tranche, the Company sold the Second Mandatory Additional Note in the aggregate principal amount of $1,500,000. The Second Mandatory Additional Note is in substantially similar form to the Initial Note.Upon issuance of the First Mandatory Additional Note, the number of Class A Ordinary Shares issuable upon exercise of the Series A Warrant automatically increased to 5,874,383 (equivalent to 293,719 Class A Ordinary Shares post Reverse Stock Split). The Second Mandatory Additional Note is included as Exhibit 4.1 in the Form 6-K filed on November 15, 2024, which is incorporated herein by reference. Fourth Tranche On April 2, 2024, the Company closed on the fourth tranche of the 2024 Debt Financing pursuant to the terms of the Securities Purchase Agreement. Under the fourth tranche, the Company sold a senior convertible note (the “Fourth Tranche Note”) in the original principal amount of $2,000,000. The Fourth Tranche Note is in substantially similar form to the Initial Note.Upon issuance of the note, the number of Class A Ordinary Shares issuable upon exercise of the Series A Warrant automatically increased to 7,961,189 (on a post Reverse Stock Split basis). The Fourth Tranche Note is included as Exhibit 4.1 in the Form 6-K filed on April 3, 2025, which is incorporated herein by reference. Between November 7, 2024 and the date of this prospectus, the Company received gross proceeds of $6,450,000 and issued an aggregate of 4,761,660 Class A Ordinary Shares (on a post-reverse stock split basis) to the Buyers. II-3 The Company may receive up to approximately $33,891,289 in additional net proceeds from the 2024 Debt Financing if (i) $6,975,000 in net proceeds are received if all remaining Additional Notes in the aggregate principal amount of $7,500,000 (together with the Fourth Tranche Note,the “Remaining Additional Notes”) issuable pursuant to the Securities Purchase Agreement are sold and (ii) the Series A Warrants are increased by 10,157,580 assuming that (A) all Remaining Additional Notes are sold and (B) an Additional Share Price is equal to $1.3513